2 results
Approved WMOCompleted
Primary Safety Objective: To describe the safety profile of 20vPnC
Approved WMORecruiting
This Phase III study, the administration of durvalumab + chemotherapy prior to surgery, followed by administration of durvalumab after surgery, will be investigated in patients with resectable Stages II and III NSCLC. The efficacy of durvalumab will…